Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: An ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis

Clinical Cancer Research

Volumn 9, Issue 2, 2003, Pages 678-685

  Marutsuka, Takashi ^a   Shimada, Shinya ^a,b   Shiomori, Kenji ^a   Hayashi, Naoko ^a   Yagi, Yasushi ^c   Yamane, Takaaki ^d   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b Yatsushiro Health Insurance General Hospital   (Japan)

^c Department of Surgery   (Japan)

^d JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 20; MESSENGER RNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER SURGERY; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LAPAROTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERITONEUM LAVAGE; PERITONEUM METASTASIS; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH CARCINOMA;

AGED; ANTIGENS, CD; ANTIGENS, CD20; BASE SEQUENCE; CARCINOEMBRYONIC ANTIGEN; DNA PRIMERS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS;

EID: 0037314675     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hiratsuka, M., Iwanaga, T., Furukawa, H., Yasuda, Y. T., Nakano, H., Nakamori, S., Daitou, H., Kameyama, M., Sasaki, H., Kou, T., Ishikawa, O., and Imaoka, M. Important prognostic factors in surgically treated gastric cancer patients (in Japanese with English abstract). Jpn. J. Cancer Chemother., 22: 703-708, 1995.
2. Yoo, C. H., Noh, S. H., Shin, D. W., Choi, S. H., and Min, J. S. Recurrence following curative resection for gastric carcinoma. Br. J. Surg., 87: 236-242. 2000.
3. Ribeiro, U., Jr., Gama-Rodrigues, J. J., Safatle-Ribeiro, A. V., Bitelman, B., Ibrahim, R. E., Ferreira, M. B., Laudanna, A. A., and Pinotti, H. W. Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. J. Gastrointest. Surg., 2: 244-249, 1998.
4. Moriguchi, S., Maehara, Y., Korenaga, D., Sugiuchi, K., and Nose, Y. Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg. Oncol., 1: 341-346, 1992.
5. Bando, E., Yonemura, Y., Takeshita, Y., Taniguchi, K., Yasusi, T., Yoshimitsu, Y., Fushida, S., Fujimura, T., Nishimura, G., and Miwa, K. Intraoperative lavage for cytological examination in 1.297 patients with gastric carcinoma. Am. J. Surg., 178: 256-262, 1999.
6. Kuroda, Y., Horikawa, N., Takada, O., Hasebe, K., Kawamura, T., Tsugawa, K., Maeda, K., Yabushita, K., Konishi, K., and Tsuji, M. Factors influencing t1 cancer of the stomach on recurrence following analysis of the clinocopathological reference and clinical course (in Japanese with English abstract). Jpn. J. Gastroenterol. Surg., 28: 1653-1659, 1995.
7. Mochizuki, F., Fujii, M., Kasakura, Y., Suzuki, T., Kanamori, N., Kochi, M., Yamagata, M., and Iwai, S. Analysis of recurrence in early gastric cancer: multivariate analysis of risk factors using logistic regression (in Japanese with English abstract). Jpn. J. Gastroenterol. Surg., 33: 440-447. 2000.
8. Shimada, S., Yagi, Y., Shiomori, K., Honmyo, U., Hayashi, N., Matsuo, A., Marutsuka, T., and Ogawa, M. Characterization of early gastric cancer and proposal of optimal therapeutic strategy. Surgery, 129: 714-719, 2001.
9. Fink, A. S., and Longmire, W. P. Carcinoma of stomach. In: D. C. Subiston (ed.), Textbook of Surgery, 14th ed., pp. 814-827. Philadelphia: WB Saunders, 1991.
10. Kodera, Y., Yamamura, Y., Shimizu, Y., Torii, A., Hirai, T., Yasui, K., Morimoto, T., and Kato, T. Peritoneal washing cytology: prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J. Surg. Oncol., 72: 60-65, 1999.
11. Burchill, S. A., Bradbury, M. F., Pittman, K., Southgate, J., Smith, B., and Selby, P. Detection of epithelial cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br. J. Cancer, 71: 278-281, 1995.
12. Vogel, I., and Kalthoff, H. Disseminated tumor cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch., 439: 109-117, 2001.
13. Johnson, P. W. M., Burchill, S. A., and Selby, P. J. The molecular detection of circulating tumor cells. Br. J. Cancer, 72: 268-276, 1995.
14. Raj, G. V., Moreno, J. G., and Gomella, L. G. Utilization of polymerase chain reaction technology in detection of solid tumors. Cancer (Phila.), 82: 1419-1442, 1998.
15. Mori, M., Mimori, K., Ueo, H., Karimine, N., Banard, G. F., Sugimachi, K., and Akiyoshi, T. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int. J. Cancer, 68: 739-743, 1996.
16. Gerhard, M., Juhl, H., Kalthoff, H., Schreiber, H. W., Wagener, C., and Neumaier, M. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J. Clin. Oncol., 12: 725-729, 1994.
17. Mori, M., Mimori, K., Inoue, H., Barnard, G. F., Tsuji, K., and Nanbara, S. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 55: 3417-3420, 1995.
18. Soong, R., Bayser, K., and Basten, O. Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin. Cancer Res., 7: 3423-3429, 2001.
19. Nakanishi, H., Kodera, Y., and Torii, A. Detection of carcinoembryonic antigen-expressing free tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn. J. Cancer Res., 88: 687-692, 1997.
20. Kodera, Y., Nakanishi, H., Yamamura, Y., Shimizu, Y., Torii, A., Hirai, T., Yasui, K., Morimoto, T., Kato, T., Koto, T., and Tatematsu, M. Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int. J. Cancer Predict. Oncol., 79: 429-433, 1998.
21. Nakanishi, H., Kodera, Y., Yamamura, Y., Ito, S., Kato, T., Ezaki, T., and Tatematsu, M. Rapid quantitative detection of carcinoembryonic antigen-expressing free tumor cells in the peritoneal cavity of gastric-cancer patients with real-time RT-PCR on the LightCycler. Int. J. Cancer Predict. Oncol., 89: 411-417, 2000.
22. Broll, R., Weschta, M., Windhoevel, U., Berndt, S., Schwandner, O., Roblick, U., Schiedeck, T. H. K., Schimmelpenning, H., Butch, Burch, H. P., and Duchrow, M. Prognostic significance of free gastrointestinal tumor cells in peritoneal lavage detected by immunocytochemistry and polymerase chain reaction. Langenbeck's Arch. Surg., 386: 285-292, 2001.
23. Funami, Y., Tokumoto, N., Miyauchi, H., Ochiai, T., and Kuga, K. Prognostic value of peritoneal lavage cytology and chemotherapy during surgery for advanced gastric cancer. Int. Surg., 84: 220-224. 1999.
24. Yu, W., Wang, I., Suh, I., Averbach, A., Chang, D., and Sugarbaker, P. H. Prospective randomized trial of early postoperative intraperitoneal chemotherapy as a adjuvant to resectable gastric cancer. Ann. Surg., 228: 347-354, 1998.
25. Sauter, T., Hofbauer, F., and Depisch, D. Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer. J. Clin. Oncol., 12: 970-974, 1994.
26. Takahashi, T., Hagiwara, A., Shimotsuma, M., Sawai, K., and Yamaguchi, T. Prophylaxis and treatment of peritoneal carcinomatosis: intraperitoneal chemotherapy with mitomycin C bound activated carbon particles. World J. Surg., 19: 565-569, 1995.
27. Kim, J. Y., and Bae, H. S. A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP). Gastric Cancer, 4: 27-33, 2001.
28. Shimada, S., Tanaka, E., Marutsuka, T., Honmyo, U., Tokunaga, H., Yagi, Y., and Ogawa, M. Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer, 5: 168-172, 2002.
29. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 1st English ed. Tokyo: Kanehara & Co., Ltd., 1999.
30. Wittwer, C. T., Harrmann, M. G., Moss, A. A., and Rasmussen, R. P. Continuous fluorescence monitoring of rapid cycle DNA amplifications. Biotechniques, 22: 130-139, 1997.
31. Abe, S., Yoshimura, H., Tabara, H., Tachibana, M., Monden, N., Nakamura, T., and Nagaoka, S. Curative resection of gastric cancer: limitation of peritoneal lavage cytology in predicting the outcome. J. Surg. Oncol., 59: 226-229, 1995.